Intestinal Pseudo-Obstruction Treatment Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Intestinal Pseudo-Obstruction Treatment market grown over the years?
The market size for the treatment of intestinal pseudo-obstruction has seen robust growth in the past years. It is predicted to expand from a value of $23.46 billion in 2024 to $24.87 billion in 2025, maintaining a compound annual growth rate (CAGR) of 6.0%. Factors responsible for this significant growth in the preceding years comprise of enhanced recognition and diagnosis, advancements in the field of medical imaging, progress in gastrointestinal motility testing and improved global healthcare access.
What Is the forecasted market size and growth rate for the intestinal pseudo-obstruction treatment market?
The market size for treating intestinal pseudo-obstruction is anticipated to witness a significant increase in the coming years. It’s forecasted to reach $30.9 billion by 2029, with a compound annual growth rate (CAGR) of 5.6%. The projected growth during the forecast period can be linked to factors such as research and drug development, telemedicine and remote monitoring, patient education and support, as well as reimbursement policies. Key trends for the forecast period are expected to be sophisticated gastrointestinal motility testing, immunomodulatory therapies, nutritional interventions, data analytics, and artificial intelligence.
Get your intestinal pseudo-obstruction treatment market report here!
What are the major factors driving growth in the intestinal pseudo-obstruction treatment market?
The increasing incidences of Parkinson’s disease are anticipated to give impetus to the expansion of the intestinal pseudo-obstruction treatment market. The disorder is recognized as a neurodegenerative ailment that impacts dopamine-producing neurons in the substantia nigra region of the brain. Individuals suffering from Parkinson’s experience a higher occurrence of IPO as it affects the enteric nervous system and causes gastrointestinal dysmotility which might lead to megacolon or intestinal blockage, including acute colonic pseudo-obstruction. Parkinson’s Foundation, a non-profit organization in the US, reported in December 2022, a 50% increase in cases with approximately 90,000 Americans being diagnosed annually, as against the previously estimated number of 60,000. Furthermore, speculations suggest that by 2030, around 1.2 million individuals around the globe will be suffering from Parkinson’s disease. Hence, the surge in Parkinson’s disease cases is impacting the growth of the intestinal pseudo-obstruction treatment market positively. An increase in cancer incidences is also projected to boost the intestinal pseudo-obstruction (IPO) treatment market. Cancer, a condition where certain cells in the body grow with no control and spread to different parts, has seen a rise due to sedentary lifestyles, unhealthy eating habits, and tobacco use. Usually, the management of IPO in cancer patients largely revolves around treating the underlying cancer, which can reduce the gastrointestinal symptoms linked to pseudo-obstruction. In October 2022, Macmillan Cancer Support, a non-profit organization in the UK, reported currently around 3 million people living with cancer in the UK with forecasts suggesting the numbers will increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the surge in cancer cases is stimulating the growth of the intestinal pseudo-obstruction (IPO) treatment market.
What key areas define the segmentation of the global intestinal pseudo-obstruction treatment Market?
The intestinal pseudo-obstruction treatment market covered in this report is segmented –
1) By Drug Class: Antibiotics, Antidepressants, Antidiarrheals
2) By Treatment: Medication, Surgery, Diet, Decompression, Other Treatments
3) By Route Of Administration: Oral, Intravenous, Other Route Of Administrations
4) By Diagnosis: Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Other Diagnosis
5) By End User: Clinic, Hospitals, Other End Users
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics
2) By Antidepressants: Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs)
3) By Antidiarrheals: Loperamide, Bismuth Subsalicylate
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12995&type=smp
What are the top market players propelling the growth of the intestinal pseudo-obstruction treatment industry?
Major companies operating in the intestinal pseudo-obstruction treatment market are F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Sanofi S.A., AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Amgen PLC, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Biogen Inc., Penn Medicine, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Allergan PLC, Torrent Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Melinta Therapeutics LLC, Tetraphase Pharmaceuticals Inc., Callisto Pharmaceuticals Inc.
What are the key trends shaping the future of the intestinal pseudo-obstruction treatment market?
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12995
What regions are dominating the intestinal pseudo-obstruction treatment market growth?
North America was the largest region in the intestinal pseudo-obstruction treatment market in 2024. The regions covered in intestinal pseudo-obstruction (IPO) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Digestive and Intestinal Remedies Global Market Report 2024
Gastrointestinal Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
